Bajaj Healthcare on Wednesday said it has forayed into the highly regulated opiate processing business.
The company said it has received two orders from the central government to produce active pharmaceutical ingredients (API) from poppy capsules and other derivatives on an annual basis.
It plans to execute both these tenders from its API manufacturing unit located at Savli, Gujarat.
"We have been awarded two tenders for the supply of Opium derived Alkaloids and APIs to the GOI, under long-term contracts and expect successive orders under similar tenders to scale up to the processing of 6,000 MT of Poppy Straw and Opium Gum in the next five years," Bajaj Healthcare Joint Managing Director Anil Jain said in a regulatory filing.
The Indian opiate market holds good potential and the receipt of this order opens the doors to a new business vertical with better margins, he added.
"This is for the first time in the history of the nation that the government has deregulated Opiate Processing to a private player, and we are extremely honoured to be awarded the very first tender in this segment," Jain said.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve hit your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Quarterly Starter
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Access to Exclusive Premium Stories Online
Over 30 behind the paywall stories daily, handpicked by our editors for subscribers


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app